Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 13Thoracic 4Dermatologic 4Head & Neck 3Breast 3Plasma cell 2Gynecologic 2Genitourinary 2Gastrointestinal 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 8Nasopharyngeal Carcinoma 5Head and Neck Neoplasms 5Stomatitis 3Sarcoma 3Mucositis 3Mouth Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Recurrence 2Prostatic Neoplasms 2Lung Neoplasms 2Differentiated Thyroid Cancer 2Carcinoma, Renal Cell 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Testicular Neoplasms 1Skin Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Lymphoma, Non-Hodgkin 1

Interventions

pembrolizumab 11Nivolumab 6Cetuximab 5Gemcitabine 4Filgrastim 4Cisplatin 4Carboplatin 4tislelizumab 3Radiosurgery 3Ipilimumab 3Injections 3Fluorouracil 3Docetaxel 3Cyclophosphamide 3Bortezomib 3toripalimab 2spartalizumab 2poly ICLC 2pazopanib 2entrectinib 2durvalumab 2cemiplimab 2belinostat 2atezolizumab 2Temozolomide 2Surveys and Questionnaires 2Riluzole 2Peripheral Blood Stem Cell Transplantation 2Oncolytic Virotherapy 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Sarcoma × Injections × Head & Neck × Clear all
NCT07491783 2026-03-24

Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial

Sichuan Enray Pharmaceutical Sciences Company

Phase 2 Not yet recruiting
52 enrolled
Head & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Sarcoma

NCT02223052 2020-05-12

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Celgene

Phase 1 Completed
89 enrolled
BreastCNSDermatologicGenitourinaryGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glioblastoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Small Cell Lung Carcinoma

NCT00918281 2014-06-09

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

GE Healthcare

Phase 2 Completed
70 enrolled 9 charts
BreastGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Head and Neck Neoplasms, Lung Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡